ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.662,38
0,08%
S&P 500
5.431,60
-0,04%
US Dollar vs BRL
5,35049
-0,49%
Bitcoin
66.254,62
0,38%
Brent Oil
82,275
0,00%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Capstone Therapeutics Corp (MM) (CAPS)

  7. Capstone Therapeutics Corp (MM) (CAPS) Notícias

CAPS

Capstone Therapeutics Corp (MM) (CAPS)

Capstone Therapeutics Corp (MM)
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CAPS
DataHoraFonteTítuloCódigoCompanhia
07/05/201810:00GlobeNewswire Inc.LipimetiX Development Announces Sub-License of Apo E Mimetic Peptide Platform to Anji Pharma, ChinaNASDAQ:CAPSCapstone Therapeutics Corp (MM)
20/07/201107:03Edgar (US Regulatory)Current report filing (8-K)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
18/07/201119:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
06/07/201109:00GlobeNewswire Inc.Capstone Therapeutics Announces Pre-Clinical Results With AZX100 in Radiation and Bleomycin Models of Pulmonary Fibrosis; PulmonNASDAQ:CAPSCapstone Therapeutics Corp (MM)
09/06/201114:21Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-A12B/A)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
08/06/201113:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (DEFA14A)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
08/06/201113:30GlobeNewswire Inc.Capstone Therapeutics Announces Adjournment of Its Annual Meeting of Stockholders and Intention to Reconvene the Meeting on JuneNASDAQ:CAPSCapstone Therapeutics Corp (MM)
31/05/201115:00GlobeNewswire Inc.Capstone Therapeutics Signs Alliance With BiolineRx to Develop Chrysalin (TP508) in Acute Myocardial InfarctionNASDAQ:CAPSCapstone Therapeutics Corp (MM)
26/05/201118:00GlobeNewswire Inc.Capstone Therapeutics Reminds Stockholders of Annual Meeting on June 6, 2011 and Encourages All Stockholders to VoteNASDAQ:CAPSCapstone Therapeutics Corp (MM)
13/05/201110:00Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
29/04/201116:12Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
27/04/201117:45GlobeNewswire Inc.Capstone Therapeutics Confirms Early Signal of AZX100 Effect Based on Final Results of Phase 2a Pilot Clinical Trial in SurgicalNASDAQ:CAPSCapstone Therapeutics Corp (MM)
04/04/201117:05GlobeNewswire Inc.Capstone Therapeutics Announces Update to Timing of Release of Final Results From AZX100 Phase 2a Pilot Clinical Trial in SurgicNASDAQ:CAPSCapstone Therapeutics Corp (MM)
29/03/201110:02Edgar (US Regulatory)Annual Report (10-K)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
11/02/201116:11Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
06/01/201119:52GlobeNewswire Inc.Capstone Therapeutics to Present at Biotech Showcase 2011NASDAQ:CAPSCapstone Therapeutics Corp (MM)
14/12/201000:18GlobeNewswire Inc.Capstone Therapeutics Announces Results of AZX100 Phase 2a Pilot Clinical Trials in Keloid and Surgical ScarringNASDAQ:CAPSCapstone Therapeutics Corp (MM)
08/12/201020:00GlobeNewswire Inc.Capstone Therapeutics to Host AZX100 Clinical Update TeleconferenceNASDAQ:CAPSCapstone Therapeutics Corp (MM)
10/11/201009:00GlobeNewswire Inc.Capstone Therapeutics Announces Third Quarter 2010 Financial ResultsNASDAQ:CAPSCapstone Therapeutics Corp (MM)
03/11/201011:00GlobeNewswire Inc.Capstone Therapeutics to Host Quarterly Update Conference CallNASDAQ:CAPSCapstone Therapeutics Corp (MM)
01/10/201020:45GlobeNewswire Inc.Capstone Therapeutics to Present at 9th Annual BIO Investor ForumNASDAQ:CAPSCapstone Therapeutics Corp (MM)
13/09/201014:00GlobeNewswire Inc.Capstone Therapeutics Announces Progress in Clinical Trials of AZX100 in Keloid ScarringNASDAQ:CAPSCapstone Therapeutics Corp (MM)
07/09/201014:00GlobeNewswire Inc.Capstone Therapeutics to Present at Rodman & Renshaw 12th Annual Healthcare ConferenceNASDAQ:CAPSCapstone Therapeutics Corp (MM)
09/08/201008:00GlobeNewswire Inc.Capstone Therapeutics Announces Second Quarter 2010 Financial ResultsNASDAQ:CAPSCapstone Therapeutics Corp (MM)
06/07/201009:00GlobeNewswire Inc.Capstone Therapeutics Announces Continuation of AZX100 Phase 2 Clinical Trial in Dermal Scarring Following Shoulder SurgeryNASDAQ:CAPSCapstone Therapeutics Corp (MM)
25/05/201017:17Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CAPSCapstone Therapeutics Corp (MM)
24/05/201008:00GlobeNewswire Inc.Capstone Therapeutics Corp. Appoints Robert J. Spiegel, MD to Board of DirectorsNASDAQ:CAPSCapstone Therapeutics Corp (MM)
21/05/201014:07GlobeNewswire Inc.Capstone Therapeutics Corp. Announces Stockholder Approval of "Put Right" and Name Change; Management to Host Conference CallNASDAQ:CAPSCapstone Therapeutics Corp (MM)
14/05/201015:00GlobeNewswire Inc.Capstone Therapeutics to Present at Rodman & Renshaw 6th Annual Global Healthcare ConferenceNASDAQ:CAPSCapstone Therapeutics Corp (MM)
12/05/201008:00GlobeNewswire Inc.Capstone Therapeutics Announces Continuation of Second of Two AZX100 Phase 2 Clinical Trials in Keloid ScarringNASDAQ:CAPSCapstone Therapeutics Corp (MM)
 Apresentando as notícias mais relevantes sobre:NASDAQ:CAPS

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
BOBR4
BOMBRIL PN
BOV
PRIO3
PETRORIO ON
BOV
OIBR3
OI ON
BOV
RENT3
LOCALIZA ON
BOV
VVEO3
CM Hospitalar ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados